Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy

被引：62
作者：
De Meerleer, Gert [1 ]
Fonteyne, Valerie [1 ]
Meersschout, Sabine [1 ]
Van den Broecke, Caroline [2 ]
Villeirs, Geert [3 ]
Lumen, Nicolaas [4 ]
Ost, Piet [1 ]
Vandecasteele, Katrien [1 ]
De Neve, Wilfried [1 ]
机构：
[1] Ghent Univ Hosp, Dept Radiat Oncol, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Pathol, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Dept Radiol, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Dept Urol, B-9000 Ghent, Belgium
来源：
RADIOTHERAPY AND ONCOLOGY | 2008年 / 89卷 / 02期
关键词：
Prostate cancer; bNED; IMRT; Prognostic factors; Salvage radiotherapy;
D O I：
10.1016/j.radonc.2008.07.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Introduction: The aim was to prospectively evaluate both acute and late toxicity and biochemical non-evidence of disease (bNED) in patients treated with salvage intensity-modulated radiotherapy (IMIRT) +/- androgen deprivation (AD) for biochemical relapse after radical prostatectomy (RP). Materials and methods: IMRT was prescribed to a mean prescription dose to the planning target volume (PTV) of 75 Gy to be delivered in 37 fractions of 2 Gy. In total, 135 patients were treated with IMRT. Median age was 64 years. Median PSA level was 0.8 ng/ml. AD was initiated in 94 patients. Indications were perineural invasion, seminal vesicle invasion or Gleason score >= 8 at RP. (1) Acute toxicity (n = 135). All patients were available for this analysis. Acute toxicity was scored using an in-house developed scoring system. (2) Late toxicity (n = 68). Only patients with a follow-up of at least 18 months were considered for late toxicity analysis. The RILIT score was used to register gastro-intestinal (GI) toxicity. An in-house developed scale was used to register genito-urinary (GU) toxicity. (3) bNED (n = 87). For bNED, all AD-naive patients (n = 38) together with the AD-positive patients with a follow-up > 18 months (n = 49) were considered. Factors influencing the results of salvage treatment were analyzed. Results: (1) Acute toxicity (n = 135). No patient developed grade 3 GI toxicity. We observed grade 2 toxicity in 20 patients. Four patients developed grade 3 GU toxicity. (2) Late toxicity (n = 68). One patient developed grade 3 rectal blood loss. One patient developed grade 3 anal pain (anal fissure). We observed grade 2 GI toxicity in 9 patients. Two patients developed grade 3 GU toxicity. Twenty-one patients developed grade 2 GU toxicity. We observed an urethral stricture in 5 patients. (3) bNED (n = 87). The 3- and 5-year bNED was 67%. Gleason score at RP, perineural invasion and capsular perforation were significant predictors for bNED. PSA before IMRT (< 1.0 vs. >= 1.0ng/ml) showed a trend in predicting bNED (p = 0.08). Conclusion: IMRT to 75 Gy +/- AD can be delivered with low levels of acute and late toxicity. In patients without perineural invasion and capsular invasion and with a Gleason score <= 7 (3 + 4), IMRT offers very good 5-years bNED. (c) 2008 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 89 (2008) 205-213.
引用
收藏
页码：205 / 213
页数：9
相关论文
共 48 条
[11]   (In)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy [J].
Choo, R ;
Hruby, G ;
Hong, J ;
Bahk, E ;
Hong, E ;
Danjoux, C ;
Morton, G ;
DeBoer, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (02) :269-276
[12]   Radical radiation for localized prostate cancer: Local persistence of disease results in a late wave of metastases [J].
Coen, JJ ;
Zietman, AL ;
Thakral, H ;
Shipley, WU .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3199-3205
[13]  
De Meerleer G, 2004, STRAHLENTHER ONKOL, V180, P136, DOI 10.1007/s00066-004-1209-2
[14]   Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients [J].
De Meerleer, G ;
Vakaet, L ;
Meersschout, S ;
Villeirs, G ;
Verbaeys, A ;
Oosterlinck, W ;
De Neve, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (03) :777-787
[15]   Intensity-modulated radiation therapy for prostate cancer: Late morbidity and results on biochemical control [J].
De Meerleer, Gert O. ;
Fonteyne, Valerie H. ;
Vakaet, Luc ;
Villeirs, Geert M. ;
Denoyette, Ludwig ;
Verbaeys, Antony ;
Lummen, Nicolas ;
De Neve, Wilfried J. .
RADIOTHERAPY AND ONCOLOGY, 2007, 82 (02) :160-166
[16]   Radiotherapy of prostate cancer with or without intensity modulated beams: A planning comparison [J].
De Meerleer, GO ;
Vakaet, LAML ;
De Gersem, WRT ;
De Wagter, C ;
De Naeyer, B ;
De Neve, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (03) :639-648
[17]   Reduction of target dose inhomogeneity in IMRT treatment planning using biologic objective functions - In response [J].
De Neve, W ;
De Gersem, W ;
De Meerleer, G ;
Claus, F ;
De Wagter, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (05) :1519-1520
[18]  
Do T, 1998, CANCER J SCI AM, V4, P324
[19]   Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer [J].
Eulau, SM ;
Tate, DJ ;
Stamey, TA ;
Bagshaw, MA ;
Hancock, SL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (04) :735-740
[20]   Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: The need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity [J].
Fonteyne, Valerie ;
De Neve, Wilfried ;
Villeirs, Geert ;
De Wagter, Cartos ;
De Meerleer, Gert .
RADIOTHERAPY AND ONCOLOGY, 2007, 84 (02) :156-163
12345